Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Gain Therapeutics reported its financial results for Q4 and full-year 2025, highlighting significant progress with its lead drug candidate GT-02287 for Parkinson's disease. Positive Phase 1b clinical data indicates disease-modifying potential, with stable clinical scores and biomarker improvements. The company plans to initiate Phase 2 trials in th…
HOOKIPA Pharma announced the completion of the sale of its immuno-oncology assets, including the HB-200 and HB-700 development programs, to NeoTrail Therapeutics. The transaction closes the sale agreement signed in January 2026. HB-200 and HB-700 are investigational immunotherapies targeting HPV16 positive cancers and KRAS-mutated cancers respectiv…
The Lovesac Company (NASDAQ: LOVE) announced financial results for fiscal 2026 with net sales increasing modestly by 2.4% to $697.1 million. Despite revenue growth driven by showroom expansion and slight comps rise, the company experienced decreases in gross profit and net income compared to fiscal 2025, impacted by increased transportation and tar…
Acumen Pharmaceuticals reported financial results for 2025, highlighting progress on its lead Alzheimer's treatment candidate sabirnetug (ACU193), including anticipation of topline Phase 2 ALTITUDE-AD study results in late 2026 and expected IND filing for its Enhanced Brain Delivery program in mid-2027. The company secured $35.75 million in private…
MapLight Therapeutics reported strong progress in its Phase 2 clinical programs, including near-completion of enrollment for the schizophrenia ZEPHYR trial and completion of enrollment for the autism spectrum disorder IRIS trial, with topline data expected in Q3 2026. The company received FDA Fast Track designation for its Alzheimer's disease psych…
Sportradar has deepened its multi-year partnership with Hard Rock Bet in the U.S. by integrating official PGA TOUR and Ultimate Fighting Championship data, enhancing in-play betting capabilities and offering dynamic micro markets and advanced visualizations to users. This expansion leverages Sportradar’s recent acquisition of IMG ARENA rights for P…
Tonix Pharmaceuticals has dosed the first participant in a Phase 1 study evaluating TNX-1900, an intranasal potentiated oxytocin formulation, in healthy volunteers to assess its potential for treating migraine and craniofacial pain by inhibiting CGRP release through a novel pathway. The study uses advanced Laser Speckle Contrast Imaging (LSCI) to m…
Hyperion DeFi, Inc., the first U.S. publicly listed DeFi company on Hyperliquid, announced robust financial results for Q4 and FY 2025. The company exceeded Q4 guidance with 64% revenue growth and 87% growth in adjusted gross profit quarter-over-quarter. It operates five diversified DeFi business lines, including staking, validator commissions, yie…
Ligand Pharmaceuticals has expanded its business development team by hiring two seasoned healthcare investors, Peter Renehan, MD and Lee Brown, and promoting Lauren Hay to Vice President of Portfolio Strategy and Investments. These hires aim to enhance Ligand's ability to source and execute royalty financing opportunities, supporting long-term valu…
Tilray Brands has announced a new licensing agreement with The Magnum Ice Cream Company to produce and distribute ready-to-drink Popsicle Hard beverages, featuring classic Popsicle flavors with 5% alcohol by volume. The product line, including Hard Cherry, Hard Orange, Hard Grape, and a seasonal Hard Firecracker flavor, targets the US adult beverag…
Lifecore Biomedical announced two new contract development and manufacturing organization (CDMO) agreements with an existing U.S.-based biopharmaceutical customer. The agreements include a site transfer for manufacturing a currently marketed product and expansion of manufacturing to a second delivery system for an ophthalmic treatment. These deals …
WeShop Holdings Limited, a US-listed social commerce platform, announced the launch of its Founders Programme in the UK. The initiative aims to empower early community creators by offering them increased referral rewards, exclusive events, and direct engagement opportunities to help grow the platform. This move is part of WeShop's strategy to accel…
Agomab Therapeutics announced that the USPTO granted a composition of matter patent for AGMB-447, its inhaled lung-restricted ALK5 inhibitor in development for idiopathic pulmonary fibrosis (IPF). This patent protection extends in the U.S. through at least 2041, supporting the company's clinical-stage pipeline targeting fibrosis. AGMB-447 is curren…
Kamada Ltd., a global biopharmaceutical leader in specialty plasma-derived therapies, announced FDA approval of its new plasma collection center in San Antonio, Texas. The facility can collect up to 50,000 liters of plasma annually, with expected revenues of $8-10 million at full capacity. This center will enhance Kamada's plasma collection capabil…
Credo's big post-earnings leg lower has created a controlled entry for traders who want exposure to one of the leading AI data-center interconnect plays. The business is growing north of 200% YoY, producing strong gross margins and free cash flow, while short interest and heavy volume make a snap-back likely if execution stays intact. I lay out a m…
Surveys published this week show consumers in Germany, France and Italy turning more pessimistic amid rising fuel prices linked to the conflict in the Middle East. Analysts warn that higher petrol costs are only the first wave of pressure on household budgets, with disrupted fertilizer flows and potential food-price increases still to come. At the …
Cibus, Inc., an agricultural technology company specializing in gene-edited plant traits, has priced a public offering of nearly 7 million Class A shares at $2.15 each, aiming to raise approximately $15 million before expenses. The proceeds will be used for working capital and to advance development of weed management traits in rice. The offering i…
A Cambodian man deported from the United States to Eswatini following completion of a 15-year attempted murder sentence has been released from prison and is being repatriated to Cambodia, his lawyer said. The release is the second confirmed of at least 19 third-country deportees the U.S. sent to Eswatini under a recent arrangement.
TransUnion announced the release date for its first quarter 2026 financial results on April 28, 2026. The company will publish a press release at 6:00 a.m. CT followed by a conference call at 8:30 a.m. CT to discuss its earnings. TransUnion is a global information and insights company specializing in credit data, fraud prevention, marketing, risk, …
Global markets reacted to conflicting messages from Washington and Tehran as fighting around the Strait of Hormuz continued. Oil prices recovered after a midweek drop, import price inflation surprised to the upside in February, and risk assets including stocks and gold struggled amid mounting concerns about future inflation and debt auctions.
UBS has cut its rating on Indian equities from Attractive to Neutral, pointing to the country's reliance on imported energy and its sensitivity to sustained oil price pressure amid an ongoing Middle East conflict. The bank highlights valuation risks for MSCI India, potential strains on the current account and corporate profits from higher energy co…
Morgan Stanley defended shares linked to memory chips after a near-term market selloff, keeping an overweight stance on Micron Technology and SanDisk. The firm argues that tightening supply fundamentals - especially as memory becomes a bottleneck for AI infrastructure and agentic CPU builds - will underpin the sector, and that recent price moves am…
UBS reiterated a positive outlook on silver, arguing that a supportive macro backdrop for real assets should underpin higher prices over time. The bank cautioned that recent liquidity-driven selling has pushed silver to roughly $60 per ounce and that near-term headwinds from industrial demand and elevated volatility could compress the metal's defic…
Barclays told clients that the combination of a sudden energy-price shock and accelerating AI-driven corporate investment supports remaining overweight U.S. equities. The bank highlighted resilient earnings momentum, adjusted valuations in Big Tech, and a policy gap between the Federal Reserve and the European Central Bank as reasons to favor the U…
The European Parliament voted to advance legislation enacting the European Union's trade commitments with the United States, with 417 in favor, 154 against and 71 abstentions. The package would remove EU import duties on U.S. industrial goods, broaden market access for American agricultural products and continue a zero-duty regime on U.S. lobsters.…
